Can You Really Know What to Expect in the Long Haul?
Ulcerative colitis is a relapsing-remitting disease, so it’s hard to predict symptoms over time. Here’s what to expect and how to recognize remission. (Source: WebMD Health)
Source: WebMD Health - December 27, 2023 Category: Consumer Health News Source Type: news
Why First Wave BioPharma Shares Are Skyrocketing Today
First Wave BioPharma, Inc. FWBI shares are skyrocketing Wednesday after the company entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases, or IBD. The IBD program that treats ulcerative colitis and related conditions was sold to an…#biopharmainc #niclosamide #ibd #firstwave #biopharma #sanofisny #adrulipase #jamessapirstein #firstwavebiopharma #fda (Source: Reuters: Health)
Source: Reuters: Health - December 27, 2023 Category: Consumer Health News Source Type: news
Biocon Biologics grants Sandoz exclusive rights to market biosimilar adalimumab in Japan
Adalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Media News - December 19, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Investor Update - December 19, 2023 Category: Pharmaceuticals Source Type: news
Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomes
(MedPage Today) -- ORLANDO -- Women with inflammatory bowel disease or relapsing multiple sclerosis who became pregnant while taking the sphingosine-1-phosphate (S1P) receptor modulator ozanimod (Zeposia) did not appear to have a higher risk... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 19, 2023 Category: Gastroenterology Source Type: news
Novel Oral Agent May Dial Down Ulcerative Colitis Severity
(MedPage Today) -- ORLANDO -- For patients diagnosed with moderate to severe ulcerative colitis, the investigational agent icanbelimod had mixed results in reducing the severity of disease within 12 weeks when used as induction and maintenance... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 19, 2023 Category: Gastroenterology Source Type: news
Shingles Vaccine Reduced Zoster Attacks in Patients With IBD
(MedPage Today) -- ORLANDO -- While patients with inflammatory bowel disease (IBD) are historically more prone to herpes zoster attacks, those who received recombinant zoster vaccines had a far lower risk of the painful rash emerging, researchers... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 18, 2023 Category: Gastroenterology Source Type: news
6 Myths About IBD, Debunked
Michelle Pickens’ symptoms escalated in college. At the time, she was throwing up at least once a day, and experiencing frequent nausea, abdominal pain, diarrhea, and constipation. Juggling classes with work at a design studio became an extreme exercise in perseverance. She knew in her gut that something was wrong.
Yet three different doctors “wrote it off as stress,” says Pickens, now 32, who lives in Annapolis, Md. Lab work and procedures to see inside her gastrointestinal tract showed nothing abnormal. “No one wanted to dig deeper,” she recalls. In a final act of desperation, Pickens sa...
Source: TIME: Health - December 18, 2023 Category: Consumer Health News Authors: Lindsay Lyon Tags: Uncategorized healthscienceclimate Source Type: news
PSMA-PET shows promise in patients with IBD
This study demonstrates that PSMA-targeted F-18 DCFPyL PET can effectively detect regions of inflamed mucosa in patients with IBD, suggesting its utility as a noninvasive imaging agent to assess location, extent, and disease activity,” the group concluded.The full study is available here. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2023 Category: Radiology Authors: Will Morton Tags: Gastrointestinal Radiology Source Type: news
Goodbye, Appendix. Hello, Crohn's Disease?
(MedPage Today) -- ORLANDO – People who undergo appendectomy may have an increased risk for the development of Crohn's disease (CD), but not ulcerative colitis (UC), according to a systematic review and meta-analysis.
The meta-analysis showed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 17, 2023 Category: Gastroenterology Source Type: news
Red Meat Consumption Tied to Higher Chance of UC Flare
(MedPage Today) -- ORLANDO – For people with inflammatory bowel disease (IBD), that hamburger may come with more than just a side of fries -- red meat consumption was linked with a higher risk for ulcerative colitis (UC) flare, researchers... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 17, 2023 Category: Gastroenterology Source Type: news
National Database Study Finds Higher Risk for Barrett ’s Esophagus in IBD
(MedPage Today) -- ORLANDO – People with inflammatory bowel disease (IBD) faced higher odds of Barrett's esophagus (BE) and BE without dysplasia, but not BE-linked malignancy, according to a cross-sectional study.
Among patients diagnosed... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 17, 2023 Category: Gastroenterology Source Type: news
Genetics group slams company for using its data to screen embryos ’ genomes
Related article
Screening embryos for IQ and other complex traits is premature, study concludes
BY
Jocelyn Kaiser
On 5 December, a U.S. company called Orchid Health announced that it would begin to offer fertility clinics and their hopeful customers the unprecedented option to sequence the whole genomes of embryos conceived by in vitro fertilization (IVF). “Find the embryo at lowest risk for a disease that runs in your family,” touts the company’s website. The cost: $2500 per embryo.
Altho...
Source: ScienceNOW - December 15, 2023 Category: Science Source Type: news
Guidelines Developed for Crohn Disease Management With Biomarkers
FRIDAY, Dec. 15, 2023 -- For patients with Crohn disease (CD), biomarkers can inform disease management in symptomatic and asymptomatic disease, according to a clinical practice guideline issued by the American Gastroenterological Association and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 15, 2023 Category: Pharmaceuticals Source Type: news
